110 related articles for article (PubMed ID: 11484115)
1. Relationships between physical activity and metacarpal cortical bone mass and bone resorption in hemiplegic patients.
Iwamoto J; Takeda T; Ichimura S
J Orthop Sci; 2001; 6(3):227-33. PubMed ID: 11484115
[TBL] [Abstract][Full Text] [Related]
2. Relationships among physical activity, metacarpal bone mass, and bone resorption marker in 70 healthy adult males.
Iwamoto J; Takeda T; Ichimura S
J Orthop Sci; 2002; 7(1):6-11. PubMed ID: 11819125
[TBL] [Abstract][Full Text] [Related]
3. Differences in bone resorption after menopause in Japanese women with normal or low bone mineral density: quantitation of urinary cross-linked N-telopeptides.
Taguchi Y; Gorai I; Zhang MG; Chaki O; Nakayama M; Minaguchi H
Calcif Tissue Int; 1998 May; 62(5):395-9. PubMed ID: 9541516
[TBL] [Abstract][Full Text] [Related]
4. Bone mineral density of metatarsus in hemiplegic subjects.
Iwamoto J; Tsukimura T; Takeda T
Am J Phys Med Rehabil; 1999; 78(3):202-7. PubMed ID: 10340415
[TBL] [Abstract][Full Text] [Related]
5. Effect of administration of lipoprostaglandin E(1) on physical activity and bone resorption in patients with neurogenic intermittent claudication.
Iwamoto J; Takeda T; Ichimura S
J Orthop Sci; 2001; 6(3):242-7. PubMed ID: 11484118
[TBL] [Abstract][Full Text] [Related]
6. Urinary excretion of type I collagen crosslinked N-telopeptides in healthy Japanese adults: age- and sex-related changes and reference limits.
Sone T; Miyake M; Takeda N; Fukunaga M
Bone; 1995 Oct; 17(4):335-9. PubMed ID: 8573404
[TBL] [Abstract][Full Text] [Related]
7. The measurement of urinary amino-terminal telopeptides of type I collagen to monitor bone resorption in patients with primary hyperparathyroidism.
Minisola S; Pacitti MT; Rosso R; Pellegrino C; Ombricolo E; Pisani D; Romagnoli E; Damiani C; Aliberti G; Scarda A; Mazzuoli SF
J Endocrinol Invest; 1997 Oct; 20(9):559-65. PubMed ID: 9413811
[TBL] [Abstract][Full Text] [Related]
8. Effect of walking exercise on bone metabolism in postmenopausal women with osteopenia/osteoporosis.
Yamazaki S; Ichimura S; Iwamoto J; Takeda T; Toyama Y
J Bone Miner Metab; 2004; 22(5):500-8. PubMed ID: 15316873
[TBL] [Abstract][Full Text] [Related]
9. Specific changes of urinary excretion of cross-linked N-telopeptides of type I collagen in pre- and postmenopausal women: correlation with other markers of bone turnover.
Gorai I; Taguchi Y; Chaki O; Nakayama M; Minaguchi H
Calcif Tissue Int; 1997 Apr; 60(4):317-22. PubMed ID: 9075625
[TBL] [Abstract][Full Text] [Related]
10. Urinary N-telopeptide levels discriminate normal, osteopenic, and osteoporotic bone mineral density.
Schneider DL; Barrett-Connor EL
Arch Intern Med; 1997 Jun; 157(11):1241-5. PubMed ID: 9183236
[TBL] [Abstract][Full Text] [Related]
11. Early changes in urinary cross-linked N-terminal telopeptides of type I collagen level correlate with 1-year response of lumbar bone mineral density to alendronate in postmenopausal Japanese women with osteoporosis.
Iwamoto J; Takeda T; Sato Y; Uzawa M
J Bone Miner Metab; 2005; 23(3):238-42. PubMed ID: 15838627
[TBL] [Abstract][Full Text] [Related]
12. Early changes in biochemical markers of bone turnover predict bone mineral density response to antiresorptive therapy in Korean postmenopausal women with osteoporosis.
Kim SW; Park DJ; Park KS; Kim SY; Cho BY; Lee HK; Shin CS
Endocr J; 2005 Dec; 52(6):667-74. PubMed ID: 16410657
[TBL] [Abstract][Full Text] [Related]
13. Markers of bone resorption predict hip fracture in elderly women: the EPIDOS Prospective Study.
Garnero P; Hausherr E; Chapuy MC; Marcelli C; Grandjean H; Muller C; Cormier C; Bréart G; Meunier PJ; Delmas PD
J Bone Miner Res; 1996 Oct; 11(10):1531-8. PubMed ID: 8889854
[TBL] [Abstract][Full Text] [Related]
14. The effect of hormone replacement therapy in postmenopausal women on urinary C-telopeptide and N-telopeptide of type I collagen, new markers of bone resorption.
Taga M; Uemura T; Minaguchi H
J Endocrinol Invest; 1998 Mar; 21(3):154-9. PubMed ID: 9591210
[TBL] [Abstract][Full Text] [Related]
15. The predictive value of biochemical markers of bone turnover for bone mineral density in postmenopausal Japanese women.
Chaki O; Yoshikata I; Kikuchi R; Nakayama M; Uchiyama Y; Hirahara F; Gorai I
J Bone Miner Res; 2000 Aug; 15(8):1537-44. PubMed ID: 10934652
[TBL] [Abstract][Full Text] [Related]
16. Increased urinary N-telopeptide cross-linked type 1 collagen predicts bone loss in patients with inflammatory bowel disease.
Dresner-Pollak R; Karmeli F; Eliakim R; Ackerman Z; Rachmilewitz D
Am J Gastroenterol; 2000 Mar; 95(3):699-704. PubMed ID: 10710060
[TBL] [Abstract][Full Text] [Related]
17. Change of cross-linked telopeptide of type I collagen (ICTP) and other bone resorption markers in patients with bone fragility fractures.
Takahara K; Kamimura M; Hashidate H; Uchiyama S; Nakagawa H
J Orthop Sci; 2007 May; 12(3):219-26. PubMed ID: 17530373
[TBL] [Abstract][Full Text] [Related]
18. Serum concentrations of cross-linked N-telopeptides of type I collagen: new marker for bone resorption in hemodialysis patients.
Maeno Y; Inaba M; Okuno S; Yamakawa T; Ishimura E; Nishizawa Y
Clin Chem; 2005 Dec; 51(12):2312-7. PubMed ID: 16223890
[TBL] [Abstract][Full Text] [Related]
19. Urinary excretion of type I collagen cross-linked N-telopeptides, bone mass and related lifestyle in middle-aged women.
Masatomi C; Imai K; Wang DH; Ikeda S; Taketa K; Takata S; Kira S
Acta Med Okayama; 1999 Jun; 53(3):133-40. PubMed ID: 10410791
[TBL] [Abstract][Full Text] [Related]
20. Urinary cross-linked N-telopeptides of type I collagen and bone metabolic diseases.
Xue Y; Jia W; Zhang H; Dong J; Clemens JD; Tian X
Chin Med J (Engl); 1999 Feb; 112(2):149-52. PubMed ID: 11593583
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]